{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:33:11Z","timestamp":1795195991267,"version":"4.10.3"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Crohn\u2019s disease (CD) is a chronic inflammatory bowel disease characterized by relapsing-remitting episodes and a progressive course that often leads to bowel damage and disability. While the etiology of CD is multifactorial, involving genetic, environmental, and immunological factors, recent studies have highlighted the role of food antigens and the gut microbiome in its pathogenesis. This paper explores the immunological underpinnings of CD, with a focus on the elevated levels of serum immunoglobulin G4 (IgG4) and their correlation with disease severity and therapeutic response. We review clinical trials and case studies that demonstrate the potential of IgG4-guided exclusion diets and intravenous immunoglobulin (IVIG) therapy in ameliorating CD symptoms and inflammation. Additionally, we delve into advancements in machine learning (ML) models that utilize fecal microbiome data, offering promising diagnostic tools for distinguishing CD from ulcerative colitis and non-IBD conditions. The integration of ML in endoscopy and predictive models for therapy complications signifies a leap toward precision medicine in IBD management. This paper underscores the necessity for a nuanced understanding of CD\u2019s immunological aspects and the innovative application of ML in its diagnosis and treatment, paving the way for personalized therapeutic strategies and improved patient outcomes.<\/jats:p>","DOI":"10.1097\/ms9.0000000000003633","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:02:04Z","timestamp":1756832524000},"page":"5798-5806","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["IgG4 unveiled: navigating the interplay with Crohn\u2019s disease \u2013 from immunology insights to machine learning"],"prefix":"10.1097","volume":"87","author":[{"given":"Anmol","family":"Mohan","sequence":"first","affiliation":[{"name":"Karachi Medical and Dental College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urooj","family":"Ghaffar","sequence":"additional","affiliation":[{"name":"Calderdale and Huddersfield NHS Foundation Trust, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Basharat","sequence":"additional","affiliation":[{"name":"Marshfield Clinic Health System, Wisconsin, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"Nawaz","sequence":"additional","affiliation":[{"name":"Marshfield Clinic Health System, Wisconsin, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Ram","family":"Khenhrani","sequence":"additional","affiliation":[{"name":"Lyari General Hospital, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Rimsha","sequence":"additional","affiliation":[{"name":"Ziauddin University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo de Jesus Aguirre","family":"Vera","sequence":"additional","affiliation":[{"name":"Tecnol\u00f3gico de Monterrey, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka Mohan","family":"Lal","sequence":"additional","affiliation":[{"name":"Ziauddin University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dev","family":"Tanush","sequence":"additional","affiliation":[{"name":"Ziauddin University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Khuzzaim","family":"Khan","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Duseja","sequence":"additional","affiliation":[{"name":"Karachi Medical and Dental College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Laiba","family":"Sherazi","sequence":"additional","affiliation":[{"name":"I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Vikash","sequence":"additional","affiliation":[{"name":"Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash","family":"Kumar","sequence":"additional","affiliation":[{"name":"The Brooklyn Hospital Center, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhairya","family":"Nanavaty","sequence":"additional","affiliation":[{"name":"The Brooklyn Hospital Center, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"R1-20251007","doi-asserted-by":"crossref","first-page":"1147\u201355","DOI":"10.1053\/j.gastro.2010.06.070","article-title":"Risk factors associated with progression to intestinal complications of Crohn\u2019s disease in a population-based cohort","volume":"139","author":"Thia","year":"2010","journal-title":"Gastroenterology"},{"key":"R2-20251007","doi-asserted-by":"crossref","first-page":"289\u201397","DOI":"10.1038\/ajg.2009.579","article-title":"The natural history of adult Crohn\u2019s disease in population-based cohorts","volume":"105","author":"Peyrin-Biroulet","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R3-20251007","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"R4-20251007","doi-asserted-by":"crossref","first-page":"137\u201351","DOI":"10.1002\/ibd.20968","article-title":"Role of diet in the development of inflammatory bowel disease","volume":"16","author":"Chapman-Kiddell","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"R5-20251007","doi-asserted-by":"crossref","first-page":"e112154","DOI":"10.1371\/journal.pone.0112154","article-title":"Serological investigation of food specific immunoglobulin g antibodies in patients with inflammatory bowel diseases","volume":"9","author":"Cai","year":"2014","journal-title":"PloS One"},{"key":"R6-20251007","first-page":"1148\u201357","article-title":"Treatment of Crohn\u2019s disease with an IgG4-guided exclusion diet: a randomized controlled trial","volume":"61","author":"Gunasekeera","year":"2016","journal-title":"Dig Dis Scie"},{"key":"R7-20251007","doi-asserted-by":"crossref","first-page":"1009\u201313","DOI":"10.1111\/j.1463-1318.2010.02373.x","article-title":"Food-specific IgG4-guided exclusion diets improve symptoms in Crohn\u2019s disease: a pilot study","volume":"13","author":"Rajendran","year":"2011","journal-title":"Colorectal Dis"},{"key":"R8-20251007","doi-asserted-by":"crossref","first-page":"252\u201364","DOI":"10.1159\/000264649","article-title":"Clinical relevance of IgG antibodies against food antigens in Crohn\u2019s disease: a double-blind cross-over diet intervention study","volume":"81","author":"Bentz","year":"2010","journal-title":"Digestion"},{"key":"R9-20251007","first-page":"408\u201314","article-title":"Immunoglobulin G4-related immune responses to common food antigens in patients with ulcerative colitis and Crohn\u2019s disease","volume":"30","author":"Sub Lee","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"R10-20251007","doi-asserted-by":"crossref","first-page":"539\u201351","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"R11-20251007","doi-asserted-by":"crossref","first-page":"83\u201390","DOI":"10.1097\/BOR.0000000000000133","article-title":"An update on IgG4-related disease","volume":"27","author":"Wallace","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"R12-20251007","doi-asserted-by":"crossref","first-page":"315\u201347","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"R13-20251007","doi-asserted-by":"crossref","first-page":"469\u201377","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"R14-20251007","doi-asserted-by":"crossref","first-page":"eaaq0997","DOI":"10.1126\/scitranslmed.aaq0997","article-title":"Laminin 511 is a target antigen in autoimmune pancreatitis","volume":"10","author":"Shiokawa","year":"2018","journal-title":"Sci Transl Med"},{"key":"R15-20251007","first-page":"728\u201335","article-title":"Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease","volume":"67","author":"Hubers","year":"2018","journal-title":"Gut"},{"key":"R16-20251007","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2018.05.011","article-title":"Identification of galectin-3 as an autoantigen in patients with IgG(4)-related disease","volume":"143","author":"Perugino","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R17-20251007","doi-asserted-by":"crossref","first-page":"2652\u201364","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N Engl J Med"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"353\u201359","DOI":"10.1136\/gut.35.3.353","article-title":"Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis","volume":"35","author":"Pullan","year":"1994","journal-title":"Gut"},{"key":"R19-20251007","doi-asserted-by":"crossref","first-page":"49\u201355","DOI":"10.1038\/s41586-019-0992-y","article-title":"Colonic epithelial cell diversity in health and inflammatory bowel disease","volume":"567","author":"Parikh","year":"2019","journal-title":"Nature"},{"key":"R20-20251007","first-page":"100082","article-title":"Transparency In The reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Premier J Sci"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2018.08.067","article-title":"Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease","volume":"175","author":"Kinchen","year":"2018","journal-title":"Cell"},{"key":"R22-20251007","doi-asserted-by":"crossref","first-page":"1268\u201373","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"key":"R23-20251007","doi-asserted-by":"crossref","first-page":"1981\u201386","DOI":"10.1073\/pnas.0307317101","article-title":"Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut","volume":"101","author":"Suzuki","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R24-20251007","first-page":"149\u201367","article-title":"The B-cell system in inflammatory bowel disease","volume":"579","author":"Brandtzaeg","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"R25-20251007","doi-asserted-by":"crossref","first-page":"434\u201343","DOI":"10.1159\/000345129","article-title":"Autophagy and Crohn\u2019s disease","volume":"5","author":"Nguyen","year":"2013","journal-title":"J Innate Immun"},{"key":"R26-20251007","doi-asserted-by":"crossref","first-page":"90\u201397","DOI":"10.1038\/nm.2069","article-title":"NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation","volume":"16","author":"Cooney","year":"2010","journal-title":"Nat Med"},{"key":"R27-20251007","doi-asserted-by":"crossref","first-page":"55\u201362","DOI":"10.1038\/ni.1823","article-title":"Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry","volume":"11","author":"Travassos","year":"2010","journal-title":"Nat Immunol"},{"key":"R28-20251007","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1053\/j.gastro.2010.07.006","article-title":"ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn\u2019s disease pathogenesis","volume":"139","author":"Homer","year":"2010","journal-title":"Gastroenterology"},{"key":"R29-20251007","doi-asserted-by":"crossref","first-page":"8392523","DOI":"10.1155\/2017\/8392523","article-title":"The interplay between defensins and microbiota in Crohn\u2019s Disease","volume":"2017","author":"Coretti","year":"2017","journal-title":"Mediators Inflamm"},{"key":"R30-20251007","doi-asserted-by":"crossref","first-page":"986789","DOI":"10.1155\/2013\/986789","article-title":"Th17 cells in immunity and autoimmunity","volume":"2013","author":"Bedoya","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R31-20251007","doi-asserted-by":"crossref","first-page":"88\u2013101","DOI":"10.1002\/cpt.893","article-title":"Anti-IL-23 and Anti-IL-17 biologic agents for the treatment of immune-mediated inflammatory conditions","volume":"103","author":"Frieder","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"R32-20251007","doi-asserted-by":"crossref","first-page":"65\u201370","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"R33-20251007","doi-asserted-by":"crossref","first-page":"1849\u201361","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J Exp Med"},{"key":"R34-20251007","doi-asserted-by":"crossref","first-page":"6313\u201318","DOI":"10.4049\/jimmunol.1001454","article-title":"Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production","volume":"186","author":"Feng","year":"2011","journal-title":"J Immunol"},{"key":"R35-20251007","doi-asserted-by":"crossref","first-page":"382\u201388","DOI":"10.1097\/01.MIB.0000218764.06959.91","article-title":"Critical role of IL-17 receptor signaling in acute TNBS-induced colitis","volume":"12","author":"Zhang","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R36-20251007","doi-asserted-by":"crossref","first-page":"1063\u201375","DOI":"10.1084\/jem.20071978","article-title":"Regulation of inflammatory responses by IL-17F","volume":"205","author":"Yang","year":"2008","journal-title":"J Exp Med"},{"key":"R37-20251007","doi-asserted-by":"crossref","first-page":"1693\u2013700","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"R39-20251007","first-page":"64\u201368","article-title":"New aspects for the therapy of Crohn\u2019s disease","volume":"68","author":"Rohr","year":"1990","journal-title":"Klin Wochenschr"},{"key":"R40-20251007","first-page":"101\u201303","article-title":"Treatment of Crohn\u2019s disease with intravenous immunoglobulin","volume":"136","author":"Wolf","year":"1988","journal-title":"Monatsschr Kinderheilkd"},{"key":"R41-20251007","first-page":"A363","article-title":"Therapy of Crohn\u2019s disease with IgM-enriched immunoglobulin","volume":"94","author":"Raedler","year":"1988","journal-title":"Gastroenterology"},{"key":"R42-20251007","doi-asserted-by":"crossref","first-page":"97\u2013103","DOI":"10.1002\/jca.2920040212","article-title":"Clinical uses of intravenous immune globulin: immunoglobulin replacement therapy and treatment of autoimmune cytopenias","volume":"4","author":"Sorensen","year":"1988","journal-title":"J Clin Apheresis"},{"key":"R43-20251007","first-page":"A397","article-title":"May the administration of high dose intravenous gammaglobulin remove a long term steroid treatment Crohn\u2019s disease?","volume":"96","author":"Possoz","year":"1989","journal-title":"Gastroenterology"},{"key":"R45-20251007","doi-asserted-by":"crossref","first-page":"385\u201386","DOI":"10.7326\/0003-4819-112-5-385","article-title":"Crohn disease and intravenous immunoglobulin G","volume":"112","author":"Knoflach","year":"1990","journal-title":"Ann Intern Med"},{"key":"R46-20251007","first-page":"64\u201368","article-title":"New aspects for the therapy of Crohn\u2019s disease","volume":"68","author":"Rohr","year":"1990","journal-title":"Klin Wochenschr"},{"key":"R47-20251007","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(87)92013-7","article-title":"Treatment of Crohn\u2019s disease and ulcerative colitis with 7S-immunoglobulin","author":"Rohr","year":"1987","journal-title":"Lancet"},{"key":"R48-20251007","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.3390\/jcm10204745","article-title":"Machine learning prediction model for inflammatory bowel disease based on laboratory markers. working model in a discovery cohort study","volume":"10","author":"Kraszewski","year":"2021","journal-title":"J Clin Med"},{"key":"R49-20251007","doi-asserted-by":"crossref","first-page":"1520\u201332","DOI":"10.1136\/gutjnl-2019-320065","article-title":"Big data in IBD: big progress for clinical practice","volume":"69","author":"Seyed Tabib","year":"2020","journal-title":"Gut"},{"key":"R50-20251007","first-page":"1\u201320","article-title":"Artificial Intelligence in Endoscopy","volume":"91","author":"Okagawa","year":"2021","journal-title":"Dig Dis Sci"},{"key":"R52-20251007","doi-asserted-by":"crossref","first-page":"e000532","DOI":"10.1136\/bmjgast-2020-000532","article-title":"High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning","volume":"7","author":"McDonnell","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"R53-20251007","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.3390\/jcm9113427","article-title":"Development of machine learning model to predict the 5-year risk of starting biologic agents in patients with inflammatory bowel disease (IBD): k-CDM network study","volume":"9","author":"Choi","year":"2020","journal-title":"J Clin Med"},{"key":"R54-20251007","doi-asserted-by":"crossref","first-page":"G328","DOI":"10.1152\/ajpgi.00360.2020","article-title":"Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases","volume":"320","author":"Manandhar","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R55-20251007","doi-asserted-by":"crossref","first-page":"872671","DOI":"10.3389\/fmicb.2022.872671","article-title":"Machine learning based microbiome signature to predict inflammatory bowel disease subtypes","volume":"13","author":"Li\u00f1ares-Blanco","year":"2022","journal-title":"Front Microbiol"},{"key":"R56-20251007","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1038\/s41467-022-34405-3","article-title":"Faecal microbiome-based machine learning for multi-class disease diagnosis","volume":"13","author":"Su","year":"2022","journal-title":"Nat Commun"},{"key":"R57-20251007","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/microorganisms12010036","article-title":"A machine learning-based diagnostic model for Crohn\u2019s disease and ulcerative colitis utilizing fecal microbiome analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Microorganisms"},{"key":"R58-20251007","first-page":"91\u2013100","article-title":"Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn\u2019s colitis","volume":"87","author":"Levine","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"R59-20251007","doi-asserted-by":"crossref","first-page":"535\u2013553.7","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the primary immunodeficiency committee of the American academy of allergy, asthma, and immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R60-20251007","doi-asserted-by":"crossref","first-page":"1460\u201380","DOI":"10.1046\/j.1537-2995.2003.00519.x","article-title":"Intravenous immune globulins: an update for clinicians","volume":"43","author":"Knezevic-Maramica","year":"2003","journal-title":"Transfusion"},{"key":"R61-20251007","first-page":"11\u201315","article-title":"The anti-inflammatory activity of IgG: the intravenous IgG paradox","volume":"204","author":"Falk","year":"2007","journal-title":"J Exp Med"},{"key":"R62-20251007","first-page":"247\u201355","article-title":"Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases","volume":"42","author":"Zandman-Goodard","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"R63-20251007","doi-asserted-by":"crossref","first-page":"275\u201380","DOI":"10.1016\/j.autrev.2012.04.006","article-title":"Intravenous immunoglobulin for the treatment of Crohn\u2019s disease","volume":"12","author":"Rogosnitzky","year":"2012","journal-title":"Autoimmun Rev"},{"key":"R64-20251007","doi-asserted-by":"crossref","first-page":"39\u201343","DOI":"10.1111\/j.1423-0410.1986.tb02006.x","article-title":"Immunoglobulin in chronic inflammatory diseases","volume":"51","author":"Cottier","year":"1986","journal-title":"Vox Sang"},{"key":"R65-20251007","doi-asserted-by":"crossref","first-page":"1573\u201383","DOI":"10.1093\/ibd\/izac115","article-title":"A systematic review of artificial intelligence and machine learning applications to inflammatory bowel disease, with practical guidelines for interpretation","volume":"28","author":"Stafford","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"R66-20251007","doi-asserted-by":"crossref","first-page":"172\u201387","DOI":"10.1007\/s12664-024-01531-3","article-title":"Artificial intelligence in endoscopy related to inflammatory bowel disease: a systematic review","volume":"43","author":"Pal","year":"2024","journal-title":"Indian J Gastroenterol"},{"key":"R67-20251007","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.3390\/diagnostics13172835","article-title":"Crohn\u2019s disease prediction using sequence based machine learning analysis of human microbiome","volume":"13","author":"Unal","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R68-20251007","doi-asserted-by":"crossref","first-page":"622934","DOI":"10.3389\/fimmu.2021.622934","article-title":"Role of the IL23\/IL17 pathway in Crohn\u2019s disease","volume":"12","author":"Schmitt","year":"2021","journal-title":"Front Immunol"},{"key":"R71-20251007","doi-asserted-by":"crossref","first-page":"819\u201329","DOI":"10.1093\/ibd\/izab187","article-title":"Machine learning predictive outcomes modeling in inflammatory bowel Diseases","volume":"28","author":"Javaid","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"R72-20251007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-022-02752-7","article-title":"The differential diagnosis of IgG4-related disease based on machine learning","volume":"24","author":"Yamamoto","year":"2022","journal-title":"Arthritis Res Ther"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:03:34Z","timestamp":1759827814000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003633","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"2025-04-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}